The Relation of 25-Hydroxyvitamin D Level with Metabolic Syndrome in Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.24293/ijcpml.v26i2.1469Keywords:
Type 2 DM, metabolic syndrome, 25(OH)DAbstract
Type 2 Diabetes Mellitus (DM) is a metabolic disorder characterized by hyperglycemia. Metabolic Syndrome (MS) is a complex metabolic disorder like hyperglycemia, obesity, dyslipidemia, and hypertension. Vitamin D controls genes associated with the regulation of insulin and renin production. The aim of this study was to analyze the relation between total levels of 25-hydroxyvitamin D [25(OH)D] and the incidence of MS in type 2 DM patients. This was an observational study with a cross-sectional design conducted from October to November 2018 in Dr. Moewardi Hospital Surakarta on 84 people with type 2 DM. All subjects were 34-75 years old. The research data were analyzed with a 2x2 test table to determine the Prevalence Ratio (PR) of each study variable, then multivariate analysis with logistic regression was continued. The mean total level of 25(OH)D was 18.01±6.10 ng/dL. Bivariate and continued with multivariate PR analysis showed poor glycemic control with the incidence of MS (PR: 11.154; 95% Cl: 3.933-31.631; p=0.001); female sex (PR : 1.788; 95% Cl: 0.750-4.261; p=0.188); age < 50 year (PR: 1.644; 95% Cl: 0.614-4.404; p=0.321); and total 25(OH)D deficiency (PR: 1.250; 95% Cl: 0.317-2.022; p=0.637). Total 25(OH)D level was not associated with the incidence of MS in the type 2 DM patients. Further study was needed using healthy group control to explain the role of vitamin D in type 2 DM.
Downloads
References
PERKENI. Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2015. In; 2015: Pengurus Besar Perkumpulan Endokrinologi Indonesia (PB PERKENI). 2015; 1-14.
International Diabetes Federation. IDF diabetes atlas. sixth Ed., 2013 [cited August 15, 2018]. Available at: www.idf.org/diabetesatlas.
Milici N. A Short history of the metabolic syndrome definitions. Proc. Rom. Acad. 2010; 13-20.
International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome.2006 [cited at Juni 15, 2018]. Available at: https://www.idf.org/component/attachments/attachments.HTML?id=705&task=download.
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical application. Chemistry & Biology, 2014; 21: 319-329.
Cí¢ndido FG, Bressan J. Vitamin D: Link between osteoporosis, obesity, and diabetes?. Int. J. Mol. Sci,
; 15: 6569-6591.
Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: A review of the role of vitamin D in
mediating susceptibility and outcome. World J Diabetes, 2015; 6(7): 896-911.
Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, e t a l . E x p r e s s i o n o f 2 5 - h y d r o x y v i t a m i n D3-1 - alpha-hydroxylase in pancreatic islets. Journal of Steroid Biochemistry & Molecular Biology, 2004; 89–90: 121-125.
Eftekhari MH, Sohrab Z, Parsa N, Nezhad MJZ. Role of gender in the prevalence of metabolic syndrome and population. Int Cardiovasc Res J, 2015; 9(4): 231-237.
Valve R, Sivenius R, Miettinen R, Pihlajamaki J, Rissanen A, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-g gene are associated with severe overweight among obese women. The Journal of Clinical Endocrinology & Metabolism, 1999; 84(10): 3708-3712.
Williams CM. Lipid metabolism in women. Proceedings of the Nutrition Society. 2004; 63: 153–160.
Prasad K, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A
community study from urban Eastern India. J Cardiovasc Dis Res, 2012; 3(3): 204-211.
Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetology and Metabolic Syndrome, 2010; 2(1): 1-5.
Kraja AT, Borecki IB, North K, Tang W, Myers RH, Hopkins PN, et al. Longitudinal and age trends of
metabolic syndrome and its risk factors: The family heart study. Nutrition & Metabolism, 2006; 3(41): 1-9.
Al LÄ°R, Sönmezer Mí‡, í‡içek AG, Keskin M, Efe FK, í‡imen Ä°M. Evaluation of the relationship between vitamin D levels and metabolic syndrome components. Biomed Res, 2017; 28(20): 8821-8826.
Gradillas-Garcíaa A, ílvarez J, Rubiob JA, de Abajo FJ. Relationship between vitamin D deficiency and
metabolic syndrome in adult population of the Community of Madrid. Endocrinol Nutr, 2015; 62(4): 180-187.
Fondjo LA, Owiredu WKBA, Sakyi SA, Laing EF, Adotey-Kwofie MA, et al. Vitamin D status and its
association with insulin resistance among type 2 diabetics: A case-control study in Ghana. 2017 [cited
a t S e p t e m b e r 1 0 , 2 0 1 8 ] A v a i l a b l e a t : https://doi.org/10.1371/journal.pone.0175388.
Tenenbaum A, Fisman EZ, Motro M. Metabolic syndrome and type 2 diabetes mellitus: Focus on
peroxisome proliferator-activated receptors (PPAR). Cardiovascular Diabetology, 2003; 2: 1-7.
Athanassiou IK, Athanassiou P, Gkountouvas A, Kaldrymides P. Vitamin D and glycemic control in
diabetes mellitus type 2. Ther Adv Endocrinol Metab, 2013; 4(4): 122-128.
Worawongprapa O. Glycemic control in diabetes with metabolic syndrome in community hospital. J Med Assoc Thai, 2008; 91(5): 641-647.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
